Mayne Pharma Group Limited (ASX:MYX)
Australia · Delayed Price · Currency is AUD 3.250
+0.170 (5.52%)
Nov 9, 2026, 10:47 AM AEDT
Mayne Pharma Group Market Cap
Mayne Pharma Group has a market cap or net worth of 266.15 million as of November 6, 2026. It is the 21,295th most valuable company in the world and the 416th biggest in Australia. Its market cap has decreased by 33.15% in one year.
Market Cap
266.15M
Enterprise Value
229.34M
Revenue
383.68M
Global Rank
Country Rank
#416 Australia
PE Ratio
15.66
ChartMarket Cap Chart
Since June 29, 2007, Mayne Pharma Group's market cap has increased from 45.66M to 266.15M, an increase of 482.89%. That is a compound annual growth rate of 9.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 8, 2026 | 266.15M | 5.33% |
| Dec 31, 2025 | 252.67M | -37.42% |
| Dec 31, 2024 | 403.79M | -19.19% |
| Dec 29, 2023 | 499.66M | 43.60% |
| Dec 30, 2022 | 347.96M | -33.16% |
| Dec 31, 2021 | 520.63M | -10.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 96.76B |
| Sigma Healthcare | 32.44B |
| Pro Medicus | 21.43B |
| Ramsay Health Care | 12.84B |
| Tetratherix | 307.74M |
| Racura Oncology | 289.20M |
| Monash IVF Group | 288.33M |
| Paragon Care | 248.30M |